title: Bone loss after orthotopic liver transplantation: FK 506 versus cyclosporine.
authors.affiliation: Mayo Clinic, Rochester, Minnesota, USA.
authors.forename: K M
authors.initials: KM
authors.lastname: Park
authors.forename: J E
authors.initials: JE
authors.lastname: Hay
authors.forename: S G
authors.initials: SG
authors.lastname: Lee
authors.forename: Y J
authors.initials: YJ
authors.lastname: Lee
authors.forename: R H
authors.initials: RH
authors.lastname: Wiesner
authors.forename: M K
authors.initials: MK
authors.lastname: Porayko
authors.forename: R A
authors.initials: RA
authors.lastname: Krom
mesh_terms: D000469:Alkaline Phosphatase / Q000097:blood; D001663:Bilirubin / Q000097:blood; D001851:Bone Diseases, Metabolic / Q000139:chemically induced; D003404:Creatinine / Q000378:metabolism; D016572:Cyclosporine / Q000009:adverse effects*; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000276:immunology; D006801:Humans; D007166:Immunosuppressive Agents / Q000276:immunology*; D016031:Liver Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D010281:Parathyroid Hormone / Q000097:blood; D010710:Phosphates / Q000097:blood; D016559:Tacrolimus / Q000009:adverse effects*; D013997:Time Factors
chemical_list: D007166:Immunosuppressive Agents; D010281:Parathyroid Hormone; D010710:Phosphates; D016572:Cyclosporine; D003404:Creatinine; D000469:Alkaline Phosphatase; D001663:Bilirubin; D016559:Tacrolimus